TagsInfectious Diseases 
China Has Begun the Monoclonal Neutralising Antibody Phase 1 Clinical Trial against COVID-19

China Has Begun the Monoclonal Neutralising Antibody Phase 1 Clinical Trial against COVID-19 China has begun the recombinant fully human monoclonal neutralising antibody (JS016) phase 1 clinical trial against COVID-19 in Shanghai on 7 June 2020 afte...

Jul 8, 2020
Clinical Trial of Antiviral for Novel Coronavirus Kick-started in China

In order to combat the current outbreak of pneumonia caused by a novel coronavirus (nCoV) reported in Wuhan, China, Chinese scientists select 30 medications including traditional Chinese medicines as candidates against nCoV 1 . In particular, an ant...

Apr 1, 2020
Early Estimation of Case Fatality Rate of COVID-19 in China

The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing and has spread to other regions in China and overseas. It has been reported that the estimated basic reproductive number (Ro) of COVID-19 repo...

Mar 25, 2020
Report on the Estimation of Basic Reproduction Number of Novel Coronavirus in China

The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing. As of 19-March, 2020, there have been more than 80,928 confirmed cases of infections and 3,245 deaths in mainland China. Besides, there are 7...

Mar 20, 2020
Suspension of Antiviral Treatment for Alleviating Drug Resistance during Influenza Pandemics

Suspension of Antiviral Treatment for Alleviating Drug Resistance during Influenza Pandemics Antiviral stockpiling is one of the actions taken by many countries and the World Health Organization (WHO) for preparation of the next influenza pandemic. ...

Mar 16, 2020